2012-05-17
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| TOP PICK | $62.230 | CAUTIOUS | NORTH AMERICAN - LARGE | Yes |
This has been one of the strong companies in the ethical drug companies. Have grown their dividend 10% at year over the last 10 years. Has been a very steady company. Traded sideways for 12 years in a price range and recently in the last year, broke out. They are going to split this company into a medical products/devices company and a pure pharma business. The pharma business will have a high yield attached and the other part has opportunities for efficiencies and growth.
David Burrows
President,
Barometer Capital Management